Tenofovir Alone May Work as Well as Truvada for Pre-exposure Prophylaxis
Tenofovir used as a single agent for pre-exposure prophylaxis (PrEP) may be as effective as the Truvada (tenofovir/emtricitabine) coformulation for preventing HIV infection, which, if confirmed, could have implications for cost and access worldwide.
HPV may be the new HIV
In Africa, both HIV and HPV are most frequently transmitted through sexual contact. Although much attention is paid to the AIDS epidemic in Africa, HPV-related cancers, particularly in people with HIV, can be as fatal as AIDS.